Skip to main content
Top
Published in: Medical Oncology 2/2024

01-02-2024 | Magnetic Resonance Imaging | Original Paper

Utility of MRI in detection of PET-CT proven local recurrence of pancreatic adenocarcinoma after surgery

Authors: D. Saponjski, A. Djuric-Stefanovic, M. Mitrovic Jovanovic, A. Jankovic, J. Kovac, S. Milosevic, K. Stosic, J. Pantovic, J. Petrovic, S. Kmezic, D. Radenkovic, D. Sobic Saranovic

Published in: Medical Oncology | Issue 2/2024

Login to get access

Abstract

The aim of this prospective study was to investigate the accuracy and inter-observer reliability of MRI in detection of local recurrence (LR) of pancreatic adenocarcinoma (PAC) after surgery, which was proved by PET-CT and access correlation between functional MRI and PET parameters. Forty-five patients who underwent PET-CT and MRI for follow-up purposes after radical operation of PAC were included. Twenty-three were PET positive (study group) and 22 negative for LR (control group). MR examination was performed within one month after PET-CT and three readers who were blind for PET-CT findings searched LR in T2W, 3D-dynamic post-contrast T1W-FS and DWI sequences, respectively. Sensitivity and specificity were calculated while inter-reader agreement was estimated by Cronbach’s Alpha reliability coefficient (CARC). Apparent diffusion coefficient (ADC) of LR was correlated with the size (maximal diameter) and functional PET-CT parameters: mean and maximum standardized uptake values (SUVmean, SUVmax), metabolic tumor volume (MTV) and total lesion glycolysis (TLG), using Spearman’s correlation coefficient (rS). Sensitivity and specificity among three readers in detecting the LR were 70% and 77–84% in T2W (CARC 0.806), 91–100% and 100% in 3D post-contrast T1W-FS (CARC 0.980), and both 100% in DWI sequences (CARC 1.000). Moderate inverse correlation was found between the ADC and SUVmean (rS = − 0.484), MTV (rS = − 0.494), TLG (rS = − 0.519) and lesion size (rS = − 0.567). MRI with DWI shows high diagnostic accuracy in detecting the LR of PAC in comparison to PET-CT as reference standard. ADC significantly inversely correlates with standard and advanced PET parameters and size of LR.
Literature
2.
go back to reference Isaji S, Mizuno S, Windsor JA, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology. 2018;18(1):2–11.CrossRefPubMed Isaji S, Mizuno S, Windsor JA, et al. International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017. Pancreatology. 2018;18(1):2–11.CrossRefPubMed
3.
go back to reference Shimada K, Sakamoto Y, Nara S, et al. Analysis of 5-year survivors after a macroscopic curative pancreatectomy for invasive ductal adenocarcinoma. World J Surg. 2010;34(8):1908–15.CrossRefPubMed Shimada K, Sakamoto Y, Nara S, et al. Analysis of 5-year survivors after a macroscopic curative pancreatectomy for invasive ductal adenocarcinoma. World J Surg. 2010;34(8):1908–15.CrossRefPubMed
4.
go back to reference Huicochea Castellanos S, Corrias G, Ulaner GA, et al. Detection of recurrent pancreatic cancer: value of second-opinion interpretations of cross-sectional images by subspecialized radiologists. Abdom Radiol. 2019;44(2):586–92.CrossRef Huicochea Castellanos S, Corrias G, Ulaner GA, et al. Detection of recurrent pancreatic cancer: value of second-opinion interpretations of cross-sectional images by subspecialized radiologists. Abdom Radiol. 2019;44(2):586–92.CrossRef
6.
go back to reference Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg. 1999;189(1):1–7.CrossRefPubMed Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. J Am Coll Surg. 1999;189(1):1–7.CrossRefPubMed
7.
go back to reference Mortel KJ, Lemmerling M, de Hemptinne B, et al. Postoperative findings following the Whipple procedure: determination of prevalence and morphologic abdominal CT features. Eur Radiol. 2000;10(1):123–8.CrossRef Mortel KJ, Lemmerling M, de Hemptinne B, et al. Postoperative findings following the Whipple procedure: determination of prevalence and morphologic abdominal CT features. Eur Radiol. 2000;10(1):123–8.CrossRef
8.
go back to reference Bluemke DA, Abrams RA, Yeo CJ, et al. Recurrent pancreatic adenocarcinoma: spiral CT evaluation following the Whipple procedure. Radiographics. 1997;17(2):303–13.CrossRefPubMed Bluemke DA, Abrams RA, Yeo CJ, et al. Recurrent pancreatic adenocarcinoma: spiral CT evaluation following the Whipple procedure. Radiographics. 1997;17(2):303–13.CrossRefPubMed
10.
go back to reference Elmi A, Murphy J, Hedgire S, et al. Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis. Abdom Radiol. 2017;42(8):2101–7.CrossRef Elmi A, Murphy J, Hedgire S, et al. Post-Whipple imaging in patients with pancreatic ductal adenocarcinoma: association with overall survival: a multivariate analysis. Abdom Radiol. 2017;42(8):2101–7.CrossRef
14.
go back to reference Ergul N, Gundogan C, Tozlu M, et al. Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography. Revi Esp Med Nucl Imagen Mol. 2014. https://doi.org/10.1016/j.remn.2013.08.005.CrossRef Ergul N, Gundogan C, Tozlu M, et al. Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography. Revi Esp Med Nucl Imagen Mol. 2014. https://​doi.​org/​10.​1016/​j.​remn.​2013.​08.​005.CrossRef
16.
go back to reference Hamidian Jahromi A, Sangster G, et al. Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19–9 levels in detecting recurrent pancreatic adenocarcinoma. JOP J Pancreas. 2013;14(4):466–8. Hamidian Jahromi A, Sangster G, et al. Accuracy of multi-detector computed tomography, fluorodeoxyglucose positron emission tomography-CT, and CA 19–9 levels in detecting recurrent pancreatic adenocarcinoma. JOP J Pancreas. 2013;14(4):466–8.
17.
go back to reference Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging. 1999;2(3):159–71.CrossRefPubMed Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging. 1999;2(3):159–71.CrossRefPubMed
18.
go back to reference Kang CM, Lee SH, Hwang HK, et al. Preoperative volume-based PET parameter, MTV25, as a potential surrogate marker for tumor biology and recurrence in resected pancreatic cancer. Medicine. 2016;95(9):e2595.CrossRefPubMedPubMedCentral Kang CM, Lee SH, Hwang HK, et al. Preoperative volume-based PET parameter, MTV25, as a potential surrogate marker for tumor biology and recurrence in resected pancreatic cancer. Medicine. 2016;95(9):e2595.CrossRefPubMedPubMedCentral
20.
go back to reference Balaj C, Ayav A, Oliver A, et al. CT imaging of early local recurrence of pancreatic adenocarcinoma following pancreaticoduodenectomy. Abdom Radiol. 2016;41(2):273–82.CrossRef Balaj C, Ayav A, Oliver A, et al. CT imaging of early local recurrence of pancreatic adenocarcinoma following pancreaticoduodenectomy. Abdom Radiol. 2016;41(2):273–82.CrossRef
21.
go back to reference Jung W, Jang J-Y, Kang MJ, et al. The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography–computed tomography (PET–CT) in follow-up of curatively resected pancreatic cancer patients. HPB. 2016;18(1):57–64.CrossRefPubMed Jung W, Jang J-Y, Kang MJ, et al. The clinical usefulness of 18F-fluorodeoxyglucose positron emission tomography–computed tomography (PET–CT) in follow-up of curatively resected pancreatic cancer patients. HPB. 2016;18(1):57–64.CrossRefPubMed
22.
go back to reference Yao X-Z, Yun H, Zeng M-S, et al. Evaluation of ADC measurements among solid pancreatic masses by respiratory-triggered diffusion-weighted MR imaging with inversion-recovery fat-suppression technique at 3.0T. Magn Reson Imaging. 2013;31(4):524–8.CrossRefPubMed Yao X-Z, Yun H, Zeng M-S, et al. Evaluation of ADC measurements among solid pancreatic masses by respiratory-triggered diffusion-weighted MR imaging with inversion-recovery fat-suppression technique at 3.0T. Magn Reson Imaging. 2013;31(4):524–8.CrossRefPubMed
23.
go back to reference Lee SS, Byun JH, Park BJ, et al. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses. J Magn Reson Imaging. 2008;28(4):928–36.CrossRefPubMed Lee SS, Byun JH, Park BJ, et al. Quantitative analysis of diffusion-weighted magnetic resonance imaging of the pancreas: usefulness in characterizing solid pancreatic masses. J Magn Reson Imaging. 2008;28(4):928–36.CrossRefPubMed
24.
go back to reference Barral M, Taouli B, Guiu B, et al. Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology. 2015;274(1):45–63.CrossRefPubMed Barral M, Taouli B, Guiu B, et al. Diffusion-weighted MR imaging of the pancreas: current status and recommendations. Radiology. 2015;274(1):45–63.CrossRefPubMed
25.
go back to reference Donswijk ML, Hess S, Mulders T, et al. [18F]Fluorodeoxyglucose PET/computed tomography in gastrointestinal malignancies. PET Clinics. 2014;9(4):421–41.CrossRefPubMed Donswijk ML, Hess S, Mulders T, et al. [18F]Fluorodeoxyglucose PET/computed tomography in gastrointestinal malignancies. PET Clinics. 2014;9(4):421–41.CrossRefPubMed
26.
go back to reference Lucignani G, Paganelli G, Bombardieri E. The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective. Nucl Med Commun. 2004;7:651–6.CrossRef Lucignani G, Paganelli G, Bombardieri E. The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective. Nucl Med Commun. 2004;7:651–6.CrossRef
27.
go back to reference Hamberg LM, Hunter GJ, Alpert NM, et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med. 1994;35(8):1308–12.PubMed Hamberg LM, Hunter GJ, Alpert NM, et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med. 1994;35(8):1308–12.PubMed
28.
go back to reference Wong CS, Gong N, Chu Y-C, et al. Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV. Eur J Radiol. 2012;9:2122–6.CrossRef Wong CS, Gong N, Chu Y-C, et al. Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV. Eur J Radiol. 2012;9:2122–6.CrossRef
29.
go back to reference Gu J, Khong P-L, Wang S, et al. Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT. Mol Imag Biol. 2011;13(5):1020–8.CrossRef Gu J, Khong P-L, Wang S, et al. Quantitative assessment of diffusion-weighted MR imaging in patients with primary rectal cancer: correlation with FDG-PET/CT. Mol Imag Biol. 2011;13(5):1020–8.CrossRef
31.
go back to reference Sakane M, Tatsumi M, Kim T, et al. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma. Acta Radiol. 2015;56(9):1034–41.CrossRefPubMed Sakane M, Tatsumi M, Kim T, et al. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma. Acta Radiol. 2015;56(9):1034–41.CrossRefPubMed
32.
go back to reference Huang WC, Sheng J, Chen SY, Lu JP. Differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis: usefulness of high b value diffusion-weighted imaging. J Dig Dis. 2011;12(5):401–8.CrossRefPubMed Huang WC, Sheng J, Chen SY, Lu JP. Differentiation between pancreatic carcinoma and mass-forming chronic pancreatitis: usefulness of high b value diffusion-weighted imaging. J Dig Dis. 2011;12(5):401–8.CrossRefPubMed
Metadata
Title
Utility of MRI in detection of PET-CT proven local recurrence of pancreatic adenocarcinoma after surgery
Authors
D. Saponjski
A. Djuric-Stefanovic
M. Mitrovic Jovanovic
A. Jankovic
J. Kovac
S. Milosevic
K. Stosic
J. Pantovic
J. Petrovic
S. Kmezic
D. Radenkovic
D. Sobic Saranovic
Publication date
01-02-2024
Publisher
Springer US
Published in
Medical Oncology / Issue 2/2024
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-023-02271-8

Other articles of this Issue 2/2024

Medical Oncology 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine